1. Home
  2. TW vs IQV Comparison

TW vs IQV Comparison

Compare TW & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TW
  • IQV
  • Stock Information
  • Founded
  • TW 1996
  • IQV 1982
  • Country
  • TW United States
  • IQV United States
  • Employees
  • TW N/A
  • IQV N/A
  • Industry
  • TW Investment Bankers/Brokers/Service
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • TW Finance
  • IQV Health Care
  • Exchange
  • TW Nasdaq
  • IQV Nasdaq
  • Market Cap
  • TW 28.0B
  • IQV 25.6B
  • IPO Year
  • TW 2019
  • IQV 2013
  • Fundamental
  • Price
  • TW $139.34
  • IQV $154.78
  • Analyst Decision
  • TW Strong Buy
  • IQV Buy
  • Analyst Count
  • TW 11
  • IQV 20
  • Target Price
  • TW $149.64
  • IQV $226.80
  • AVG Volume (30 Days)
  • TW 976.9K
  • IQV 2.3M
  • Earning Date
  • TW 07-30-2025
  • IQV 07-21-2025
  • Dividend Yield
  • TW 0.35%
  • IQV N/A
  • EPS Growth
  • TW 29.22
  • IQV 0.26
  • EPS
  • TW 2.43
  • IQV 7.35
  • Revenue
  • TW $1,823,739,000.00
  • IQV $15,497,000,000.00
  • Revenue This Year
  • TW $23.19
  • IQV $5.37
  • Revenue Next Year
  • TW $11.08
  • IQV $5.19
  • P/E Ratio
  • TW $57.14
  • IQV $21.12
  • Revenue Growth
  • TW 28.94
  • IQV 2.84
  • 52 Week Low
  • TW $102.79
  • IQV $134.65
  • 52 Week High
  • TW $152.65
  • IQV $252.88
  • Technical
  • Relative Strength Index (RSI)
  • TW 48.30
  • IQV 55.12
  • Support Level
  • TW $137.14
  • IQV $153.23
  • Resistance Level
  • TW $139.01
  • IQV $159.85
  • Average True Range (ATR)
  • TW 3.13
  • IQV 4.39
  • MACD
  • TW -0.19
  • IQV 0.96
  • Stochastic Oscillator
  • TW 48.43
  • IQV 67.09

About TW Tradeweb Markets Inc.

Founded in 1998 and headquartered in New York City, Tradeweb Markets is a leading fixed-income trading platform. While it does offer electronic processing for some voice-negotiated trades, the company focuses primarily on providing electronic trading networks that connect broker/dealers, institutional clients, and retail customers. While the company offers trading in a wide variety of products, the bulk of its business is in U.S. and European government debt, mortgage-backed securities, interest-rate swaps, and U.S. and international corporate bonds. The firm also sells fixed-income trading and price data, primarily through a deal with Refinitiv's Eikon service.

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: